Senior Manager, Market Access, Pricing & Government Affairs

ジェンマブは革新的な抗体医薬の開発に注力し、患者さんの生活を改善することに力を尽くしています。

私たちは、extra[not]ordinary® な未来を共に築くことを使命とし、革新的な抗体製品の開発や人々を感動させる抗体医薬品で、がんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え、治療の未来を切り拓いています。

ジェンマブは思いやりがあり、率直で、患者さんに貢献したいという強い思いを持った人たちがともに働き、科学に基づく変化をもたらします。大胆さと高潔性を持って行動し、新しい未来をつくることを目指すこと が、この使命を果たすために不可欠だと信じています。

私たちは大きな志を掲げ、楽しく、そして思いやりの心を忘れずに、日々意義のある仕事に取り組んでいます。私たちは、個々のユニークな貢献を受け入れ、それらを原動力として、患者、ケアパートナー、ご家族、そして社員のニーズを満たす革新的なソリューションを生み出し、育み、維持するグローバルな企業文化の構築に努めています。

私たちの想いに共鳴し、自分らしく活躍できそうだと感じたら、ぜひ一緒に働きましょう。

The Role & Department

Senior Manager, Market Access, Pricing & Government Affairs will report to the Director, Market Access, Pricing & Government Affairs. The role includes negotiating drug prices with the Ministry of Health, Labour and Welfare (MHLW) and managing preparation for those negotiations; contributing to drug development and commercialization from a pricing strategy perspective; forecasting prices for both marketed and pipeline products; monitoring and sharing updates on pharmaceutical policy within the company, and developing and implementing strategies in response to government actions; as well as participating in industry association activities.

• Lead drug pricing negotiation with the MHLW for both new products and marketed products, and manage preparation for the negotiation
• Participate in clinical development planning and commercial strategy discussions and provide input from a pricing strategy perspective.
• Develop future price forecasts for both upcoming and currently marketed products and formulate strategies to maintain more favorable pricing over time.
• Collect the latest information on government developments and key policy movements, and formulate appropriate countermeasures. Share information about critical policy developments affecting Market Access & Pricing and provide input to internal stakeholders with those that require strategic attention.
• Engage in external industry activities representing Genmab to collect insights through networking, as well as to contribute to developing industry position.

• Leading drug pricing negotiations with the MHLW for new pharmaceutical products is required
• Negotiating products in the oncology and/or hematology fields is preferred.
• Participating in HTA (Health Technology Assessment) / cost-effectiveness evaluation processes with the MHLW and C2H (Center for Outcomes Research and Economic Evaluation for Health) is preferred.
• Developing and maintaining pricing assumptions and forecasts for marketed and pipeline products in collaboration with other departments (e.g., Development, Regulatory Affairs, Commercial functions) is required.
• Working in a multinational company is preferred.

• Bachelor's degree in relevant fields; Pharmacy, Medicine, Biotechnology, or a related field preferred.
• Strong analytical and critical thinking skills.
• Strong PC skills, including proficiency in Microsoft Excel and PowerPoint.
• Strong interpersonal and communication skills.
• Strong expertise in Japanese National Health Insurance drug pricing rules and reimbursement system
• Strong knowledge of the Japanese healthcare system and pharmaceutical industry
• Understanding of pharmacy, medicine, and biotechnology.
• Experience in related functions such as Regulatory Affairs, Clinical Development, Marketing, Market Research, Medical or Finance is a plus.
• Native-level Japanese proficiency, including excellent written and verbal communication skills, is required.
• Working proficiency in English and the ability to collaborate with global stakeholders are preferred